Advanced drug delivery systems can assist in targeting coronavirus disease (COVID-19): A hypothesis
Meenu Mehta(University of Technology Sydney), Kamal Dua(University of Technology Sydney), Madhur D. Shastri(University of Tasmania), Parteek Prasher(University of Petroleum and Energy Studies), Krishnan Anand(University of the Free State), Manish Vyas(Lovely Professional University), Mousmee Sharma(Uttaranchal University), Dinesh Kumar Chellappan(Ajman University), Saurabh Satija(Lovely Professional University), Harish Dureja(Maharshi Dayanand University), Gaurav Gupta(Gyan Vihar University), Navneet Khurana(Lovely Professional University)
Cited by 46
Related Papers
Lipid-Based Nanoparticles for Drug/Gene Delivery: An Overview of the Production Techniques and Difficulties Encountered in Their Industrial Development
|ACS Materials Au|2023|570
Endoplasmic Reticulum Stress and Oxidative Stress: A Vicious Nexus Implicated in Bowel Disease Pathophysiology
|International Journal of Molecular Sciences|2017|285
Treatment strategies against diabetes: Success so far and challenges ahead
|European Journal of Pharmacology|2019|239
The potential of siRNA based drug delivery in respiratory disorders: Recent advances and progress
|Drug Development Research|2019|181
Exploring the contribution of pro-inflammatory cytokines to impaired wound healing in diabetes
|Frontiers in Immunology|2023|179